DyI(2) reacts with 2 equiv of KOAr (OAr = OC(6)H(3)(CMe(3))(2)-2,6) under nitrogen to form not only the (N(2))(2-) complex, [(ArO)(2)(THF)(2)Dy](2)(mu-eta(2):eta(2)-N(2)), 1, but also complexes of similar formula with an added potassium ion, [(ArO)(2)(THF)Dy](2)(mu-eta(2):eta(2)-N(2))[K(THF)(6)], 2, and [(ArO)(2)(THF)Dy](2)(mu(3)-eta(2):eta(2):eta(2)-N(2))K(THF), 3. The 1.396(7) and 1.402(7) A N-N bond distances in 2 and 3, respectively, are consistent with an (N(2))(3-) ligand, but the high magnetic moment of 4f(9) Dy(3+) precluded definitive identification. The Y[N(SiMe(3))(2)](3)/K reduction system was used to synthesize yttrium analogues of 2 and 3, {[(Me(3)Si)(2)N](2)(THF)Y}(2)(mu-eta(2):eta(2)-N(2))[K(THF)(6)] and {[(Me(3)Si)(2)N](2)(THF)Y}(2)(mu(3)-eta(2):eta(2):eta(2)-N(2))K, that had similar N-N distances and allowed full characterization. EPR, Raman, and DFT studies are all consistent with the presence of (N(2))(3-) in these complexes. (15)N analogues were also prepared to confirm the spectroscopic assignments. The DFT studies suggest that the unpaired electron is localized primarily in a dinitrogen pi orbital isolated spatially, energetically, and by symmetry from the metal orbitals.
No takes yet. Share an insight, caveat, or question.
Evans et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: